The Critical Role of Faecalibacterium prausnitzii in Cardiovascular Diseases.

IF 1.9 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Reviews in cardiovascular medicine Pub Date : 2025-03-20 eCollection Date: 2025-03-01 DOI:10.31083/RCM26740
Tiantian Zheng, Chenchen Meng, Zhengtian Lv, Chenxia Wu, Xinbin Zhou, Wei Mao
{"title":"The Critical Role of <i>Faecalibacterium prausnitzii</i> in Cardiovascular Diseases.","authors":"Tiantian Zheng, Chenchen Meng, Zhengtian Lv, Chenxia Wu, Xinbin Zhou, Wei Mao","doi":"10.31083/RCM26740","DOIUrl":null,"url":null,"abstract":"<p><p>Due to the continued aging of the global population, cardiovascular diseases (CVDs) remain the main cause of death worldwide, with millions of fatalities from diseases, including stroke and coronary artery disease, reported annually. Thus, novel therapeutic approaches and targets are urgently required for diagnosing and treating CVDs. Recent studies emphasize the vital part of gut microbiota in both CVD prevention and management. Among these, <i>Faecalibacterium prausnitzii</i> (<i>F. prausnitzii</i>) has emerged as a promising probiotic capable of improving intestinal health. Although preliminary investigations demonstrate that <i>F. prausnitzii</i> positively enhances cardiovascular health, research specifically connecting this strain to CVD outcomes remains limited. Based on current research and assessment of possible clinical applications, this paper aimed to investigate the positive effects on cardiovascular health using <i>F. prausnitzii</i> and its metabolites. Targeting gut flora is expected to become a mainstay in CVD treatment as research develops.</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":"26 3","pages":"26740"},"PeriodicalIF":1.9000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11951488/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in cardiovascular medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.31083/RCM26740","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Due to the continued aging of the global population, cardiovascular diseases (CVDs) remain the main cause of death worldwide, with millions of fatalities from diseases, including stroke and coronary artery disease, reported annually. Thus, novel therapeutic approaches and targets are urgently required for diagnosing and treating CVDs. Recent studies emphasize the vital part of gut microbiota in both CVD prevention and management. Among these, Faecalibacterium prausnitzii (F. prausnitzii) has emerged as a promising probiotic capable of improving intestinal health. Although preliminary investigations demonstrate that F. prausnitzii positively enhances cardiovascular health, research specifically connecting this strain to CVD outcomes remains limited. Based on current research and assessment of possible clinical applications, this paper aimed to investigate the positive effects on cardiovascular health using F. prausnitzii and its metabolites. Targeting gut flora is expected to become a mainstay in CVD treatment as research develops.

prausnitzii粪杆菌在心血管疾病中的关键作用。
由于全球人口持续老龄化,心血管疾病仍然是全世界死亡的主要原因,每年报告有数百万人死于中风和冠状动脉疾病等疾病。因此,迫切需要新的治疗方法和靶点来诊断和治疗心血管疾病。最近的研究强调了肠道微生物群在心血管疾病预防和治疗中的重要作用。其中,prausnitzii粪杆菌(F. prausnitzii)已成为一种有希望改善肠道健康的益生菌。虽然初步调查表明F. prausnitzii积极促进心血管健康,但专门将该菌株与CVD结果联系起来的研究仍然有限。基于目前的研究和临床应用评估,本文旨在探讨prausnitzii及其代谢物对心血管健康的积极作用。随着研究的发展,靶向肠道菌群有望成为心血管疾病治疗的支柱。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Reviews in cardiovascular medicine
Reviews in cardiovascular medicine 医学-心血管系统
CiteScore
2.70
自引率
3.70%
发文量
377
审稿时长
1 months
期刊介绍: RCM is an international, peer-reviewed, open access journal. RCM publishes research articles, review papers and short communications on cardiovascular medicine as well as research on cardiovascular disease. We aim to provide a forum for publishing papers which explore the pathogenesis and promote the progression of cardiac and vascular diseases. We also seek to establish an interdisciplinary platform, focusing on translational issues, to facilitate the advancement of research, clinical treatment and diagnostic procedures. Heart surgery, cardiovascular imaging, risk factors and various clinical cardiac & vascular research will be considered.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信